comprehensive -WSS

comprehensive

author：entertainment 2025-10-01 22:16:45 - browse：76

Blood corpuscles in clot — Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success. David Gregory & Debbie Marshall/Wellcome Images

Vascular device maker Inari Medical announced plans to buy LimFlow, a company selling a last-line therapy to save legs with blocked blood flow, on Wednesday. Inari will pay $250 million upfront and $165 more depending on LimFlow’s commercial success.

LimFlow recently snagged Food and Drug Administration approval for its surgical system that uses a stent to connect a blocked artery to an open vein, thus allowing blood to flow through and heal injuries. The tool is meant only for patients with a severe form of peripheral artery disease, and who have already tried more conservative options.

Dan Rose, CEO of LimFlow, previously told STAT that his mission is to fight the amputation epidemic in the United States, which disproportionately impacts Black patients. Experts cautioned to STAT that expanding screenings to catch the disease early is still the most important measure.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： One Duchenne patient's bittersweet hope for new treatment

leisure time

WSS

Judge schedules Friday hearing on proposed protective order in Jan. 6 case

Trump attorney outlines possible Jan. 6 legal defenses, but some experts are skeptical

In venture capital firm's success, lessons for turning crisis into profit

Women's World Cup brings attention to abuse in soccer

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

Choosing scientific sides in the fight against Alzheimer's

hotspot

comprehensive

explore

BioMarin wins approval for gene therapy to treat hemophilia A

Giant panda gives birth to squirming, squealing healthy twin girls at South Korean theme park

Apple is now the first public company to be valued at $3 trillion

Inflation cooled significantly in June, bringing price hikes close to normal levels

After affirmative action ruling, medical educators look to 'holistic review'

Choosing scientific sides in the fight against Alzheimer's

Medical leaders decry Supreme Court decision on affirmative action

An Ebola outbreak presents a new mystery involving children

The high cost of giving birth even with insurance

Kerry to visit Beijing for climate talks amid efforts to revive relations between US and China

explore

Lessons Learned: This is why you network to find that industry job you want

A Greenpeace activist is fined for crash

China sends large group of warplanes, navy ships towards Taiwan in forceful display

Mega Millions jackpot estimated at record $1.58 billion for Tuesday's drawing

Cheesesteak restaurant owner explains his secret sauce, the viral Malibu Barbie Dream Drizzle

In venture capital firm's success, lessons for turning crisis into profit

hotspot

leisure time

leisure time

Wikipedia